Nordihydroguaiaretic acid (NDGA), a dual inhibitor of IGF-IR and ErbB2, was shown to promote cell death in trastuzumab resistant human breast cancer cell lines [39]. The gene discussed is IGF1R; the disease is breast carcinoma.